Multiple Myeloma in Relapse Clinical Trials in Omaha, Nebraska
2 recruitingOmaha, Nebraska
Showing 1–2 of 2 trials
Recruiting
Phase 2
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
CellCentric Ltd.100 enrolled20 locationsNCT07096778
Recruiting
Phase 2
A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Oncotherapeutics39 enrolled2 locationsNCT06115135